Jacob Waldrop
Fortuna: 575 053 $ al 30/06/2026
Fortuna: 575 053 $ al 30/06/2026
Jacob A. Waldrop is Chief Operating Officer at Sanara MedTech, Inc. since 2024.
Formerly, Mr. Waldrop was Chief Financial Officer at Trilliant Surgical LLC and Vice President-Finance & Integrations at Enovis Corp.
Mr. Waldrop completed undergraduate studies at Texas A&M University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SANARA MEDTECH, INC. 0,27 % | 15/04/2026 | 24.377 ( 0,27 % ) | 575 053 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANARA MEDTECH INC. | Director de Operaciones | 15/04/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Director Financiero/CFO | - |
| ENOVIS CORPORATION | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Sanara MedTech, Inc.
Sanara MedTech, Inc. Medical SpecialtiesHealth Technology Provides medical products, advanced biotechnology solutions and applications | Health Technology |
Enovis Corp.
Enovis Corp. Medical SpecialtiesHealth Technology Develops, manufactures and supplies medical devices used for reconstructive surgery, rehabilitation, pain management and physical therapy | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trilliant Surgical LLC
Trilliant Surgical LLC Medical SpecialtiesHealth Technology Designs, develops, manufactures and distributes small bone podiatric implants | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.